Elanco Animal Health has announced a new global research and development collaboration with AgBiome, to develop nutritional health products for pigs.
The collaboration will leverage AgBiome’s proprietary strain identification system and provide Elanco access to AgBiome’s extensive and growing collection of bacteria, viral and fungal strains. Terms of the deal have not been disclosed.
Elanco will combine AgBiome’s success in crop science with its expertise in animal health to bring innovative new solutions. This agreement furthers Elanco’s targeted, value-generating IPP strategy (innovation, portfolio and productivity).
Aaron Schacht, Elanco’s executive vice president of innovation, regulatory and business development, said: “AgBiome’s vast strain library and unique knowledge and methods for strain identification and development are particularly interesting to Elanco.
“Identifying and developing new products and tools to help manage the animal’s microbiome, control infections, and reduce gut inflammation, while decreasing the need for medically important antibiotics is a top priority for Elanco.”
Eric Ward, co-CEO of AgBiome, added: “We are excited to be creating novel products for animal nutrition using the microbial technology and data science tools in our Genesis platform.”